Therini Bio, Inc.
Clinical-stage company focused on developing biologics that specifically block innate immune activation triggered by toxic fibrin deposits, with the aim of treating Alzheimer’s Disease and retinal disorders.
Clinical-stage company focused on developing biologics that specifically block innate immune activation triggered by toxic fibrin deposits, with the aim of treating Alzheimer’s Disease and retinal disorders.
Waypoint Bio is leveraging the power of spatial biology to revolutionize cell therapy development, particularly for solid tumors
An RNA trans-splicing company developing programmable RNA repair medicines
Rhino solves one of the biggest challenges in the AI and data space, by seamlessly connecting siloed data through federated computing.
Finally, expert neurological care without the wait.
Developing the next generation of life-saving regenerative medicines with the world's most advanced ML cell imaging platform.
A pre-clinical stage biopharmaceutical company focusing on treating the leading causes of blindness through choroidal and retinal revascularization.
Developing therapeutics for underserved rare genetic neurodevelopmental disorders by gene therapy and RNA-based therapeutics.
A clinical-stage biopharmaceutical company dedicated to the development of innovative neuropsychiatric medicines.
Unleashing machine learning to solve medicinal chemistry.
Emotionally intelligent AI Care Management to elevate your clinical operations.
A pioneer in drug discovery and development, leveraging their unique Kinetic Ensemble platform to develop innovative small molecule precision medicines for oncology.